| 摘要 |
Compounds useful for the treatment of disorders of the serotonin-affected neurological systems are provided which have formula (I) wherein: X is carbon or nitrogen; the dotted line represents an optional bond which is absent when X = N; R1 and R2 are each, independently, hydrogen, halogen, CF3, alkyl, alkoxy, or MeSO2; R3 is hydrogen, halogen, or alkyl; R4 is hydrogen, alkyl, alkylaryl, or aryl; and R5 is hydrogen, halogen, CF3, CN, carbamide, or alkoxy; or a pharmaceutically acceptable salt thereof. |
